Diplomat Pharmacy (DPLO) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Diplomat Announces 2nd Quarter Financial Results
August 9, 2016 4:15 PM EDTFLINT, Mich., Aug. 9, 2016 /PRNewswire/ --Â Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended June 30, 2016. Â All comparisons, unless otherwise noted, are to the quarter ended June 30, 2015.
Second Quarter 2016 Highlights include:
Revenue of $1,089 million, an increase of 35% or $281 million 23% organic revenue growth Total prescriptions dispensed of 241,000, an increase of... More


